Skip to main content
. 2023 Sep 8;67(10):e00301-23. doi: 10.1128/aac.00301-23

Fig 6.

Fig 6

Simulation of expected in vitro effects (lower panel) in combination for typical concentration profiles (upper panel) obtained in patients after standard CZA (2/0.5 g q8h as 2 h infusion) and CST (9 MIU CMS + 4.5 MIU CMS q12h as 30 min infusion) doses.